May 183 minSoliton Announces Pivotal Cellulite Clinical Trial Results to be Presented at AAD Virtual Meeting June 12-14 AAD 2020 VMX Virtual Meeting Experience held June 12-14, 2020 online at aad.org HOUSTON, Texas, May 18, 2020 /PRNewswire/ -- S...
Apr 304 minCNS Pharmaceuticals and WPD Pharmaceuticals Identify Leading Polish Medical Institutions forBerubicin Phase 2 Clinical Trial Trials in Poland to be funded by a $6 million grant previously awarded to WPD Pharmaceuticals HOUSTON, April 30, 2020 /PRNew...
Apr 283 minMoleculin Approved to Accelerate European Clinical TrialRegulatory authorization doubles dose escalation in Annamycin AML trial HOUSTON, April 28, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Mol...
Apr 234 minCNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug BerubicinHOUSTON, April 23, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the develo...
Apr 213 minMoleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team Dr. Richard Whitley, a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and...
Apr 152 minCNS Pharmaceuticals Announces Shareholder Webinar to Discuss Collaboration with WPD Pharmaceuticals for Developing Coronavirus Drug Candidates, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin HOUSTON, April 15, 2...
Apr 153 minMoleculin Announces Leading Virologist Joins Development TeamFollows discovery that active compound in WP1122 reduces in vitro replication of SARS-CoV-2 HOUSTON, April 15, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., ...
Apr 143 minMoleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug CandidateFollows discovery that active compound in WP1122 reduces in vitro replication of SARS-CoV-2 by 100% HOUSTON, April 14, 2020 /PRNewswire/ -- Moleculin Biotech...
Apr 133 minCNS Pharmaceuticals Announces Independent University Research Confirms Active Compound in WP1122 Completely Prevents Coronavirus Replication In Vitro; WP1122 is Subject to Development Agreement with WPD Pharmaceuticals CNS Pharmaceuticals to receive 50% ...
Apr 112 minVerb Technology Company – Consenus Indicates Potential 171.8% UpsideVerb Technology Company found using ticker (VERB) have now 2 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges betw...
Apr 115 min3 Biotech Stocks Under $2 With Massive Upside PotentialJust in time for Easter, the market delivered two consecutive sessions of gains. All three of the major U.S. stock indexes closed in the green on the last tw...
Apr 83 minSoliton Granted New Key Patent for FDA Cleared RAP Technology- Extends Rapid Acoustic Pulse technology broad patent portfolio - HOUSTON, April 8, 2020 /PRNewswire/ -- Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Com...
Apr 84 minMoleculin Announces Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100%Independent research shows 2-DG activity against virus that causes COVID-19 HOUSTON, April 8, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("...
Mar 299 minWeyland Tech Reports Revenue up 86% to Record $10.0 Million in Q4 2019, and up 53% to Record $34.6 Million for the Full Year NEW YORK, March 30, 2020 (GLOBE NEWSWIRE) -- Weyland Tech, Inc. (OTCQX: WEYL), a leading global provider of mCommer...
Mar 234 minVERB Bd Member and Former Apple Exec to Host Interactive Video Webinar to Introduce New Remote Working and Selling Tool: VERB LIVE NEWPORT BEACH, Calif. and SALT LAKE CITY, March 23, 2020 (GLOBE NEWSWIRE) -- VERB Technology Comp...
Mar 233 minSoliton to Present Pivotal Cellulite Clinical Trial Results at Virtual AAD 2020 Annual Meeting- Leading dermatologist, Dr. Elizabeth Tanzi, to present pivotal cellulite trial results - HOUSTON, March 23, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SO...
Mar 233 minCNS Pharmaceuticals Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for a Range of Viruses including Coronavirus for International Markets HOUSTON, March 23, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Co...
Mar 203 minMoleculin Announces Patent Filing to Cover New Coronavirus Drug CandidateHOUSTON, March 20, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with ...
Mar 195 minWeyland Tech Provides Corporate UpdateNEW YORK, March 19, 2020 (GLOBE NEWSWIRE) -- Weyland Tech, Inc. (OTCQX: WEYL) (OTCQX: WEYLD), a leading global provider of mCommerce platform-as-a-service (P...
Mar 184 minMoleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, Including CoronavirusIndependent research suggests new approach to inhibiting the viral replication capability of a range of viruses, including Coronavirus HOUSTON, March 17, 202...
